Cargando…
Aspects of prophylactic treatment of hemophilia
Retrospective and prospective studies unambiguously show that prophylactic treatment of severe hemophilia A or B should be started as primary prophylaxis at 1–2 years’ of age and ideally before the first joint bleed. The dose and dose frequency should be individually tailored depending on the goal o...
Autor principal: | Ljung, Rolf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5056524/ https://www.ncbi.nlm.nih.gov/pubmed/27766056 http://dx.doi.org/10.1186/s12959-016-0103-3 |
Ejemplares similares
-
Prevention and Management of Bleeding Episodes in Children with Hemophilia
por: Ljung, Rolf C. R.
Publicado: (2018) -
Patient and parent preferences for characteristics of prophylactic treatment in hemophilia
por: Furlan, Roberto, et al.
Publicado: (2015) -
Principles of care for acquired hemophilia
por: Dolan, Gerry, et al.
Publicado: (2021) -
Once-weekly prophylactic dosing of recombinant factor IX improves adherence in hemophilia B
por: Djambas Khayat, Claudia
Publicado: (2016) -
Concizumab as a Subcutaneous Prophylactic Treatment Option for Patients with Hemophilia A or B: A Review of the Evidence and Patient’s Perspectives
por: Pasca, Samantha
Publicado: (2022)